INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 March 2014
|
Total net assets |
£190m |
|
NAV per share |
344.8p |
|
Share price |
280.5p |
|
Total value of unquoted investments |
£26m |
|
Total number of portfolio companies |
99 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Biogen |
7.2 |
|
Gilead |
6.6 |
|
Alexion |
6.3 |
|
Celgene |
5.4 |
|
Amgen |
4.2 |
|
Regeneron |
4.0 |
|
Illumina |
3.2 |
|
Vertex |
3.0 |
|
Aptiv |
3.0 |
|
Mylan |
3.0 |
|
|
----------- |
|
Total |
45.9 |
|
Trust Characteristics |
% NAV |
|
Profitable |
57 |
|
Turning Profitable 2015 |
10 |
|
Unprofitable |
33 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
United States & Canada |
91 |
|
Europe & UK |
9 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% NAV |
|
Quoted |
87 |
|
Unquoted |
13 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
14 APRIL 2014